This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1990 Jul 7;336(8706):24.

New evidence on xamoterol

No authors listed

PMID: 1973213

Editorial

New evidence on xamoterol

No authors listed. Lancet. 1990.

. 1990 Jul 7;336(8706):24.

PMID: 1973213

No abstract available

PubMed Disclaimer

Comment in

Xamoterol in severe heart failure.
Ikram H, Crozier IG. Ikram H, et al. Lancet. 1990 Aug 25;336(8713):517-8. doi: 10.1016/0140-6736(90)92078-v. Lancet. 1990. PMID: 1975033 No abstract available.

Comment on

Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.
[No authors listed] [No authors listed] Lancet. 1990 Jul 7;336(8706):1-6. Lancet. 1990. PMID: 1694945 Clinical Trial.

Similar articles

[Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
Fukuda K, Handa S, Ogawa S, Nakamura Y, Kawamura Y. Fukuda K, et al. Kokyu To Junkan. 1988 Nov;36(11):1227-33. Kokyu To Junkan. 1988. PMID: 2907820 Japanese. No abstract available.
Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris.
European 'Corwin' Study Group. European 'Corwin' Study Group. Br J Clin Pharmacol. 1989;28 Suppl 1(Suppl 1):67S-69S. Br J Clin Pharmacol. 1989. PMID: 2572258 Free PMC article.
Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.
[No authors listed] [No authors listed] Lancet. 1990 Jul 7;336(8706):1-6. Lancet. 1990. PMID: 1694945 Clinical Trial.
Long-term studies with xamoterol in heart failure.
Waller DG. Waller DG. Br J Clin Pharmacol. 1989;28 Suppl 1(Suppl 1):53S-58S. doi: 10.1111/j.1365-2125.1989.tb03573.x. Br J Clin Pharmacol. 1989. PMID: 2572255 Free PMC article. Review.
The efficacy of xamoterol in heart failure of ischemic origin.
Marlow HF. Marlow HF. J Cardiovasc Pharmacol. 1989;14 Suppl 5:S69-72. J Cardiovasc Pharmacol. 1989. PMID: 2478814 Review. No abstract available.

See all similar articles

Cited by

Paradoxical and bidirectional drug effects.
Smith SW, Hauben M, Aronson JK. Smith SW, et al. Drug Saf. 2012 Mar 1;35(3):173-89. doi: 10.2165/11597710-000000000-00000. Drug Saf. 2012. PMID: 22272687 Review.
Lack of pharmacodynamic interactions between acute dose flosequinan and xamoterol. A pilot study in healthy subjects.
Ng HW, Walley TJ, Tsao Y, Breckenridge AM. Ng HW, et al. Eur J Clin Pharmacol. 1994;46(4):361-5. doi: 10.1007/BF00194406. Eur J Clin Pharmacol. 1994. PMID: 7957523 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information